Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
2.060
+0.020 (0.98%)
Feb 21, 2025, 4:00 PM EST - Market closed
Adagene Market Cap
Adagene has a market cap or net worth of $91.20 million as of February 21, 2025. Its market cap has decreased by -38.81% in one year.
Market Cap
91.20M
Enterprise Value
16.31M
1-Year Change
-38.81%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $91.20M, a decrease of -88.66%. That is a compound annual growth rate of -41.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 91.20M | 3.52% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |